TAREQ ABUASAB to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications TAREQ ABUASAB has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.250
-
Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies. Haematologica. 2024 01 01; 109(1):293-297.
Score: 0.129
-
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. Am J Hematol. 2023 06; 98(6):E142-E144.
Score: 0.122